Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System rece...
06 April 2021 - 3:00PM
Philips SmartCT 3D image acquisition, visualization and measurement
software for its Azurion Image Guided Therapy System receives FDA
510(k) clearance
April 6, 2021
- Intuitive, table-side touchscreen control offers
interventionalists enhanced diagnostic confidence and streamlined
workflows [1]
- Full control of image acquisition and analysis from within the
sterile zone helps to avoid procedure disruption, saving time and
allowing interventionalists to stay focused on their patients
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced U.S. Food and Drug Administration 510 (k) clearance for
its Philips SmartCT application software. SmartCT is a key
component of Philips Image Guided Therapy System – Azurion –
providing interventionalists with CT-like 3D images (Cone Beam CT)
to support diagnosis, therapy planning, treatment and follow-up for
interventional radiology procedures. Bringing intuitive touchscreen
control of advanced 3D image acquisition, visualization,
vessel/organ segmentation, and quantitative measurements to the
table-side, within the interventional lab’s sterile zone, SmartCT
helps enhance clinical confidence, smooths workflows, and increases
productivity. It includes software applications for angiography,
neurology, soft-tissue imaging, and guidewire/catheter navigation,
supporting a wide range of procedures such as the treatment of
aneurysms, vascular diseases and liver tumors.
Philips’ latest Azurion image-guided therapy platform integrates
essential lab systems and tools needed for complex interventional
procedures into an uncluttered laboratory environment in which
interventionalists can focus on treating the patient rather than
being distracted by the technology. SmartCT brings total control of
the Azurion platform to a touchscreen tablet situated alongside the
interventional radiology table. This eliminates the need for
clinicians to leave the sterile field and step into an adjacent
control room, as well as supporting faster and better-informed
decision making.
“A key part of our image-guided therapy strategy is to combine
high-quality, low X-ray dose imaging with a superior user
experience that allows interventional radiologists to diagnose and
treat patients as part of smoother, safer and less interrupted
workflows,” said Ronald Tabaksblat, General Manager Image Guided
Therapy Systems at Philips. “Philips SmartCT is a major step
forward in 3D imaging, enhancing confidence in the interventional
suite and supporting key elements of the quadruple aim of better
patient outcomes, enhanced patient and staff experiences and lower
cost of care.”
“Changing to a new technology can be challenging, but if the
system itself can show you the way, it makes it much easier to
adopt new advances,” Prof. Hicham Kobeiter, Chief of Radiology and
Interventional Radiology, Hôpitaux Universitaires Henri-Mondor in
Crétiel, France. “SmartCT leads you through each step of the
procedure, bringing us more confidence and more precision across
cardiovascular, oncology and emergency cases.”
“With the new SmartCT interface we can go into more detail more
quickly and safely, with fewer staff in the room,” said Prof. Marc
Sopval, Interventional Radiologist at Hôpital Européen Georges
Pompidou AP-HP in Paris, France. “SmartCT has brought Cone Beam CT
to life in everyday practice: all the tools and guidance
capabilities are used by the entire team each day.”
With SmartCT, users are guided through the image acquisition
process and can review and interact with the acquired CT-like 3D
images on the system’s table-side touch screen module using 3D
visualization and measurement tools. These tools have been designed
to support procedures in a range of clinical domains, including
neurology, oncology, and cardiovascular procedures, and feature
intuitive two-point distance measurements on 3D images, the ability
to remove structures from the images that obstruct the region of
interest, and the ability to select and store optimum projection
angles for recall during procedures.
Philips SmartCT image acquisition, visualization and measurement
software is an integral part of the next-generation Philips Image
Guided Therapy System – Azurion – which was launched in September
2020, marking an important step forward in optimizing clinical and
operational lab performance and expanding the role of image-guided
interventions in the treatment of patients. Azurion has achieved
rapid global adoption, reflecting the accelerating trend toward
minimally-invasive surgery thanks to its benefits in terms of
reduced patient trauma, shorter recovery times and hospital stays,
and lower healthcare costs.
[1] Evaluated with clinical users in a simulated lab environment
with a total of 17 teams consisting of a physician and an
interventional radiology technologist with different levels of
experience.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916E-mail: mark.groves@philips.com
Fabienne van der FeerPhilips Image Guided TherapyTel: + 31 622
698 001E-mail : fabienne.van.der.feer@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips SmartCT prostatic artery embolization
- Philips SmartCT neurology
- Philips SmartCT tableside monitor
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024